Announced details
Up to approximately 80% reduction in post-treatment volume
Approximately 25% reduction in post-treatment weight
First installation at a testing center in Japan (cumulative installations: Not disclosed)
The Machida Institute of Public Health adopted and installed equipment handled by the company’s group company, 株式会社セントラル科学貿易. 株式会社セントラル科学貿易 is the equipment’s import distributor.
Machida, Tokyo. Representative Director: Nikaido Tetsuya (二階堂哲也). Testing and research facility.
Machida Institute of Public Health (Machida, Tokyo)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | STERILWAVE (infectious medical waste sterilization and volume- and weight-reduction system) |
| Counterparty | Machida Institute of Public Health |
| Counterparty overview | Machida, Tokyo. Representative Director: Nikaido Tetsuya (二階堂哲也). Testing and research facility. |
| Relationship with the Company | The Machida Institute of Public Health adopted and installed equipment handled by the company’s group company, 株式会社セントラル科学貿易. 株式会社セントラル科学貿易 is the equipment’s import distributor. |
| Launch date | 14 September 2026 (already installed) |
| Applicable area | Infectious medical waste treatment, Medical institutions, Testing and research facilities, Local waste treatment during disasters |
| Location | Machida Institute of Public Health (Machida, Tokyo) |
| Quantitative Effects | Up to approximately 80% reduction in post-treatment volume, Approximately 25% reduction in post-treatment weight |
| Usage history | First installation at a testing center in Japan (cumulative installations: Not disclosed) |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The equipment will process infectious medical waste continuously generated at the institute and strengthen the local waste treatment system during emergencies such as disasters. The company also cites rising treatment costs for infectious medical waste and the environmental impact of incineration as background issues.